Regeneron Pharmaceuticals Inc.
REGN · Large Cap · NASDAQ · Healthcare · Biotechnology
$805.46−$13.63 (-1.66%)
Market closed · opens in 1d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on REGN
Free to track. No card required. Usually ready in 10-15 minutes.
Where REGN sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$541.00
High$821.11
Today $805.46
RSI (14)
73.8Overbought
03070100
Stocksbrew score
64/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$730
Current price
$805.46
Median target
$860
Highest
$1,030
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 38% below avg
12.34x
Debt / equity
Favorable · 0.09 - strong leverage
0.09x
Current ratio
Strong · Good liquidity position
3.34x
How it stacks up against its peers
REGN against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $81.41B | 19.5 | +9.3% | 64 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |